Icrucumab (Anti-VEGFR1 / FLT1)
Icrucumab (Anti-VEGFR1 / FLT1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody, with potential anti-tumor and anti-metastatic agent. It also act as a therapeutic anti-angiogenic agent in different pathological contexts.
Supplier | Selleck Chemicals |
---|---|
Product # | A2301 |
Sku # | A2301-1mg*25 |
Pricing | 1mg*25, $2370.00 |